BACKGROUND: Patients with COPD face an increased risk of cardiovascular disease and increased cardiac mortality. Carotid femoral pulse wave velocity (cf-PWV) is a validated measure of arterial stiffness, a well recognized predictor of adverse cardiovascular outcomes, and offers higher predictive value than classical cardiovascular risk factors. We investigated the association between COPD and arterial stiffness using cf-PWV as a noninvasive technique. METHODS: This clinical study was prospective, observational, and cross-sectional. Sixty-two subjects with stable COPD and 22 healthy controls underwent physical examination, chest x-rays, pulmonary function tests, arterial blood gas analysis, and 6-min walk test, and cf-PWV was measured via a validated tonometry system. RESULTS: The COPD subjects had greater arterial stiffness than the control subjects, and that difference was associated with lower FEV1, PaO2, and oxygen saturation during the 6-min walk test. We observed higher cf-PWV in the COPD subjects with severe COPD than in the subjects with mild to moderate COPD. Only FEV1 was an independent predictor of cf-PWV. CONCLUSIONS: Our results suggest that arterial stiffness is increased in subjects with more severe and advanced COPD than in those with mild to moderate COPD. Air flow limitation and hypoxemia may induce increased arterial stiffness in COPD patients.
BACKGROUND:Patients with COPD face an increased risk of cardiovascular disease and increased cardiac mortality. Carotid femoral pulse wave velocity (cf-PWV) is a validated measure of arterial stiffness, a well recognized predictor of adverse cardiovascular outcomes, and offers higher predictive value than classical cardiovascular risk factors. We investigated the association between COPD and arterial stiffness using cf-PWV as a noninvasive technique. METHODS: This clinical study was prospective, observational, and cross-sectional. Sixty-two subjects with stable COPD and 22 healthy controls underwent physical examination, chest x-rays, pulmonary function tests, arterial blood gas analysis, and 6-min walk test, and cf-PWV was measured via a validated tonometry system. RESULTS: The COPD subjects had greater arterial stiffness than the control subjects, and that difference was associated with lower FEV1, PaO2, and oxygen saturation during the 6-min walk test. We observed higher cf-PWV in the COPD subjects with severe COPD than in the subjects with mild to moderate COPD. Only FEV1 was an independent predictor of cf-PWV. CONCLUSIONS: Our results suggest that arterial stiffness is increased in subjects with more severe and advanced COPD than in those with mild to moderate COPD. Air flow limitation and hypoxemia may induce increased arterial stiffness in COPDpatients.
Entities:
Keywords:
COPD; cardiovascular disease; clinical respiratory medicine; inflammation; respiratory function test
Authors: Lidia Tomkiewicz-Pajak; Hanna Dziedzic-Oleksy; Jacek Pajak; Maria Olszowska; Jacek Kolcz; Monika Komar; Piotr Podolec Journal: Cardiovasc Ultrasound Date: 2014-04-10 Impact factor: 2.062
Authors: Marie Fisk; Carmel M McEniery; Nichola Gale; Kaisa Mäki-Petäjä; Julia R Forman; Margaret Munnery; Jean Woodcock-Smith; Joseph Cheriyan; Divya Mohan; Jonathan Fuld; Ruth Tal-Singer; Michael I Polkey; John R Cockcroft; Ian B Wilkinson Journal: Hypertension Date: 2018-01-22 Impact factor: 10.190
Authors: Jilles M Fermont; Katya L Masconi; Magnus T Jensen; Renata Ferrari; Valéria A P Di Lorenzo; Jacob M Marott; Philipp Schuetz; Henrik Watz; Benjamin Waschki; Hana Müllerova; Michael I Polkey; Ian B Wilkinson; Angela M Wood Journal: Thorax Date: 2019-01-07 Impact factor: 9.139
Authors: Maurice Roeder; Noriane A Sievi; Dario Kohlbrenner; Christian F Clarenbach; Malcolm Kohler Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-01-23